These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

Empowered Funds LLC grew its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 6.5% during ...

I will start by saying that biotechnology is a game Changer, it has revolutionised various fields, including medicare, agricultural business, industrial engineering and environmental science, ...

Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Biogen in a research note ...

LIXTE Biotechnology (LIXT) announced the closing of its previously announced registered direct offering priced at-the-market ...

Brent Sabatini, the Senior Vice President and Chief Accounting Officer at Vir Biotechnology, Inc. (NASDAQ:VIR), recently sold 1,562 shares of the company's common stock. According to InvestingPro data ...

LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical ...

Project Vital is a statewide initiative to invest in research, workforce development, and biotech startups, positioning Virginia as a leader in biotechnology. Virginia Tech, Carilion Clinic, and the ...

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used ...

Prime Minister Narendra Modi met Indian-American entrepreneur Vivek Ramaswamy in Washington to discuss India-US relations, ...